西證國際證券(00812.HK)中期淨虧1.27億港元 同比擴大111.40%
格隆匯 8 月 31日丨西證國際證券(00812.HK)公告,截至2020年6月30日止6個月,集團實現收益總額1.29億港元,同比收窄1.98%;公司擁有人應占虧損1.27億港元,同比擴大111.40%;每股基本虧損3.474港仙;不派中期股息。
新冠肺炎疫情影響,2020年上半年僅有64家新上市公司(包括5家由GEM轉主板上市的公司),按年減少20家或下降23.8%。因此,香港交易所首次上市集資總額排名從去年第一下跌至2020年上半年第三,僅次於納斯達克股票交易所及上海證券交易所。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.